Results 251 to 260 of about 366,968 (314)

Association Between SGLT2 Inhibitor Use and Reduced Risk of Liver-Related Events, Including Hepatocellular Carcinoma, in Diabetic Patients with Viral Hepatitis: A Nationwide Cohort Study. [PDF]

Cancers (Basel)
Kang SH, Choi J, Yim HJ, Jung YK, Yim SY, Lee YS, Seo YS, Kim JH, Yeon JE, Byun KS.   +9 more
europepmc   +1 more source

MASLD and viral hepatitis overlap: An emerging dual burden in chronic liver disease. [PDF]

Hepatol Forum
Ejaz M, Kumar K, Sohail D, Sarfaraz I, Azam H, Yaseen F.   +5 more
europepmc   +1 more source

Comprehensive Bioinformatics Analysis the circRNAs of Viral Infection Associated Pathway in HepG2 Expressing ORF3 of Genotype IV Swine Hepatitis E Virus. [PDF]

Microorganisms
Jiao H, Wang L, Meng C, Wu S, Qi Y, Guo J, Li J, Cao L, Zhao Y, Wen JJ, Wang F.   +10 more
europepmc   +1 more source

Conservative Treatment of HAV-Associated Acalculous Acute Cholecystitis in an Adult: A Case Report. [PDF]

Case Rep Med
Medina-Ramirez SA, Arones-Santayana CA, Huamani EC, Diaz-Reyes N.   +3 more
europepmc   +1 more source

A Decade of the National Center for HIV, Viral Hepatitis, STD, and TB Prevention's Epidemiologic and Economic Modeling Agreement. [PDF]

Public Health Rep
Abimbola TO, Van Handel M, Marks SM, Beeler Asay GR, Sandul A, Gift TL, Durham MD, Pampati S, Salomon JA, Martin EG, Mermin J.   +10 more
europepmc   +1 more source

Key Challenges in Screening Blood Donors for Hepatitis B Virus. [PDF]

Viruses
Badawi MA, Eldakhakhny S, Ali M, Badawi M, Khiariy J, Bin-Taleb Y, Hindawi SI.   +6 more
europepmc   +1 more source